Day: November 11, 2022

VANCOUVER, British Columbia, Nov. 11, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today reported financial results for the first quarter of fiscal year 2023, ended September 30, 2022. The Company’s condensed financial statements and related MD&A for the first quarter of fiscal year 2023, ended September 30, 2022 will be available at www.inmedpharma.com and at www.sedar.com. Eric A. Adams, InMed CEO, states, “In the first quarter of our new fiscal year, we continue to strengthen our pharmaceutical pipeline in dermatology, ocular and neurodegenerative diseases, as well as continue to screen our library of proprietary analogs for additional therapeutic candidates....

TORONTO, Nov. 11, 2022 (GLOBE NEWSWIRE) — All per share figures disclosed below are stated on a diluted basis.         For the periods ended September 30, Three months   Nine months  ($ in thousands, except per share amounts)   2022     2021     2022     2021         Net revenue $ 72,226   $ 72,384   $ 221,400   $ 207,038Operating earnings   16,047     20,771     52,570     59,474Net gains (losses)   (19,835 )   (8,146 )   (117,945 )   90,292Net earnings (loss)   (6,548 )   8,597     (68,957 )   126,289                  EBITDA(1) $ 24,410   $ 27,349   $ 76,372   $ 78,333Adjusted cash flow from operations(1)   17,743     23,219     56,177     65,571                           Attributable to shareholders:        Net earnings (loss) $ (7,608 ) $ 7,054   $ (73,044 ) $ 121,817EBITDA(1)   ...

VANCOUVER, British Columbia, Nov. 11, 2022 (GLOBE NEWSWIRE) —  Novo Resources Corp. (“Novo” or the “Company”) (TSX: NVO, NVO.WT & NVO.WT.A) (OTCQX: NSRPF) reports its financial results for the nine-month period ended September 30, 2022. All amounts are expressed in Canadian dollars, unless otherwise noted. This news release should be read together with Novo’s management’s discussion and analysis (the “MD&A”) and condensed interim consolidated financial statements (the “Financial Statements”) for the nine-month period ended September 30, 2022 (“YTD 2022”) which are available under Novo’s profile on SEDAR (www.sedar.com). The three-month period ended September 30, 2022 is referred to as “Q3 2022” in this news release. Q3 2022 HighlightsRevenue of $28.0 million from the sale of 12,426 ounces of gold from the Company’s...

MONTRÉAL, Nov. 11, 2022 (GLOBE NEWSWIRE) — MONARCH MINING CORPORATION (“Monarch” or the “Corporation”) (TSX: GBAR) (OTCQX: GBARF) reported its results today for the first quarter ended September 30, 2022. Amounts are in Canadian dollars unless otherwise indicated. Summary of financial results(In dollars except per-share data) Three-month periods ended September 30  2022   2021  Revenues 2,005,605   –  Cost of sales (16,672,139 ) –  Loss from mine operations (14,666,534 ) –  Administration expenses (928,785 ) (1,915,029 )Exploration expenses (141,313 ) (1,729,695 )Finance expenses (389,471 ) (136,972 )Revaluation of financial liabilities on tonnes milled at the Beacon Mill 480,084   –  Change in fair value of investments (179,218 ) –  Gain on disposal of assets –   7,690,483  Impairment of property,...

FREMONT, Calif., Nov. 11, 2022 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT networks, today reported financial results for the fiscal third quarter and first nine months ended September 30, 2022. Financial Highlights:Total revenue increased 5% year-over-year to $6.3 million for the nine-months ended September 30, 2022. Delivery of Sales to IoT- customers grew 45% year-over-year for the nine-months ended September 30, 2022. Backlog of customer open orders of $3.9 million (of which 84% are for IoT customers) as of September 30, 2022. Gross Margin at 48.3% for the nine-months ended September 30, 2022 compared to 50% in the prior year period, due to ongoing inflationary and supply-chain pressures. Significant...